Chiara Schiavi

Update upon the infection risk in patients receiving TNF alpha inhibitors

F. Giusti, S. Negrini, G. Murdaca, 2019, Expert opinion on drug safety.

Systemic Sclerosis and Vaccinations: A Register-Based Cohort Study about Seasonal Influenza and Streptococcus pneumoniae Vaccination Rate and Uptake from Liguria Regional Center, Northwest Italy

L. Sticchi, F. Giusti, G. Icardi, 2020, Vaccines.

Genetic Factors and Psoriatic Arthritis

F. Giusti, S. Negrini, G. Murdaca, 2019, Open Journal of Rheumatology and Autoimmune Diseases.

Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient

P. Queirolo, F. Giusti, G. Murdaca, 2020, Frontiers in Immunology.

Recurrence of COVID-19 related symptoms and viral detection in a patient discharged after complete recovery and test negativization

F. Giusti, S. Negrini, R. De Palma, 2021 .

Evaluation of Frequency of CMV Replication and Disease Complications Reveals New Cellular Defects and a Time Dependent Pattern in CVID Patients

Genny Del Zotto, Andrea Guastalla, Chiara Schiavi, 2024, Journal of clinical immunology.

Arterial thrombosis triggered by methotrexate-induced hyperhomocysteinemia in a systemic lupus erythematosus patient with antiphospholipid antibodies

Chiara Schiavi, Luca Marri, Simone Negrini, 2023, Thrombosis Journal.

Immunogenicity of infliximab and adalimumab

F. Giusti, S. Negrini, G. Murdaca, 2019, Expert opinion on drug safety.